III: Normal to pathological aging and LOE – Part 2
Clinical point of view; Challenges in neuropsychology ; Round Table Discussion III: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future; IV: Neurological comorbidities
Neurodegenerative disorders; Aging with encephalopathies: extra long-term follow-up; Round Table Discussion IV: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future
break
V: New diagnostic approaches
Structural and functional imaging as biomarkers;
Seizures: age-specific semiology, detection and prediction;
Round Table Discussion V: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future
break
VI: Old and new therapeutic approaches
LOE–seizure risk, etiologies and indication for ASM;
Age-dependency in ASM – real world data;
Age-dependency in vagal nerve stimulation ;
Adherence or compliance: the age-related characteristics;
Round Table Discussion VI: Speakers and Coparticipants: Caveats for science and patients care, recommendations, tasks for the future.
VII: Summarizing Joint Session and Closing remarks
Caveats for science and patients care, recommendations, tasks for the future from the conference participants, also in view of ALOE_2028
